Immunome
IMNM
IMNM
26 hedge funds and large institutions have $7.35M invested in Immunome in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Holders
26
Holding in Top 10
–
Calls
$147K
Puts
–
Top Buyers
| 1 | +$42K | |
| 2 | +$32K | |
| 3 | +$24.1K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.58K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$6K |
Top Sellers
| 1 | -$510K | |
| 2 | -$226K | |
| 3 | -$159K | |
| 4 |
Cerity Partners
New York
|
-$118K |
| 5 |
LNWWM
Laird Norton Wetherby Wealth Management
San Francisco,
California
|
-$102K |